This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux Sa. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Laurence Becquart: Innovator in Monoclonal Antibodies
Introduction
Laurence Becquart is a notable inventor based in Saint Priest, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
Laurence Becquart holds a patent for "Monoclonal antibodies directed against hepatitis B viruses." This invention relates to a monoclonal antibody capable of binding to a wild-type HBsAg antigen and to at least one, preferably at least two, and advantageously more than two, mutant forms of the HBsAg antigen. The monoclonal antibody binds to a peptide sequence consisting of at least six contiguous amino acids in the 199-208 region of the HBsAg antigen, and advantageously binds to the peptide sequence constituted by the 199-208 region of the HBsAg antigen. He has 1 patent to his name.
Career Highlights
Laurence Becquart is associated with the company bioMérieux SA, where he has been instrumental in advancing research and development in the field of diagnostics and therapeutics. His work has contributed to the understanding and treatment of hepatitis B, showcasing his commitment to improving public health.
Collaborations
He has collaborated with notable coworkers, including Colette Jolivet-Reynaud and Mylene Lesenechal, who have supported his research endeavors.
Conclusion
Laurence Becquart's innovative work in monoclonal antibodies represents a significant advancement in the fight against hepatitis B. His contributions continue to impact the field of biotechnology and public health positively.